Scholars@Duke

Randomized  Controlled Trials Versus Real-World Data in the COVID-19 Era: A False Narrative.

Publication ,  Journal Article
Lyman, GH; Kuderer, NM
Published in: Cancer Invest
November 2020
Published version (DOI) Link to item

Duke Scholars

Gary Herbert Lyman
Author Gary Herbert Lyman Medicine, Medical Oncology
Altmetric Attention Stats
Dimensions Citation Stats

Published In

Cancer Invest

DOI

10.1080/07357907.2020.1841922

EISSN

1532-4192

Publication Date

November 2020

Volume

38

Issue

10

Start / End Page

537 / 542

Location

England

Related Subject Headings

  • SARS-CoV-2
  • Research Design
  • Randomized Controlled Trials as Topic
  • Oncology & Carcinogenesis
  • Observational Studies as Topic
  • Humans
  • Evidence-Based Medicine
  • COVID-19
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H., & Kuderer, N. M. (2020). Randomized  Controlled Trials Versus Real-World Data in the COVID-19 Era: A False Narrative. Cancer Invest, 38(10), 537–542. https://doi.org/10.1080/07357907.2020.1841922
Lyman, Gary H., and Nicole M. Kuderer. “Randomized  Controlled Trials Versus Real-World Data in the COVID-19 Era: A False Narrative.” Cancer Invest 38, no. 10 (November 2020): 537–42. https://doi.org/10.1080/07357907.2020.1841922.
Lyman GH, Kuderer NM. Randomized  Controlled Trials Versus Real-World Data in the COVID-19 Era: A False Narrative. Cancer Invest. 2020 Nov;38(10):537–42.
Lyman, Gary H., and Nicole M. Kuderer. “Randomized  Controlled Trials Versus Real-World Data in the COVID-19 Era: A False Narrative.” Cancer Invest, vol. 38, no. 10, Nov. 2020, pp. 537–42. Pubmed, doi:10.1080/07357907.2020.1841922.
Lyman GH, Kuderer NM. Randomized  Controlled Trials Versus Real-World Data in the COVID-19 Era: A False Narrative. Cancer Invest. 2020 Nov;38(10):537–542.

Published In

Cancer Invest

DOI

10.1080/07357907.2020.1841922

EISSN

1532-4192

Publication Date

November 2020

Volume

38

Issue

10

Start / End Page

537 / 542

Location

England

Related Subject Headings

  • SARS-CoV-2
  • Research Design
  • Randomized Controlled Trials as Topic
  • Oncology & Carcinogenesis
  • Observational Studies as Topic
  • Humans
  • Evidence-Based Medicine
  • COVID-19
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis